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Lower limb bilateral pyomyositis  
in a diabetic patient: case report  
and literature review
ABSTRACT
Pyomiositis is a bacterial infection of skeletal muscle 
tissue occurring mostly in immunocompromised pa-
tients, including diabetics. The main agents are Gram-
-positive cocci. We report a case of a 42 years old, male, 
diabetic, who presented the emergency room referring 
pain in thighs and inability to flex his legs. We per-
formed a magnetic resonance which revealed extensive 
purulent collections in both lower limbs, thus confirm-
ing clinical suspicion, and allowing proper antibiotic 
treatment. In this case, we showed that imaging tests 
facilitate early diagnosis and treatment through direct 
location of the lesions, and guides invasive procedures 
such as biopsy and abscess aspiration when needed. 
(Clin Diabetol 2020; 9)
Key words: pyomyositis, diabetes mellitus type 2, 
magnetic resonance imaging
Introduction
Scriba, in 1885, reported the first case of pyomyosi-
tis [1], as a primary acute bacterial infection of skeletal 
muscle’s tissue [1, 2]; it occurs mainly in immunocom-
promised patients [3], malnurished [4] or, exceptionally, 
in immunocompetent patients in tropical areas [3]. In 
fact, it was originally described as a tropical disease 
and is now being seen, with increasing frequency, in 
temperate regions; pyomyositis holds a mortality rate 
of about 10% and may also be responsible for compli-
cations such as abscesses, septicemia, and shock [2].
The pathogenesis of primary pyomyositis remains 
unclear, although trauma and immune impairment can 
be predisposing factors [2]. It affects individuals, pref-
erably during the first and second decades of life, and 
is more prevalent in men [1]; patients over 30 years of 
age usually have associated comorbidities [5], and the 
most described in the literature are human immunode-
ficiency virus infection [6], diabetes mellitus, malignant 
tumors, liver cirrhosis, renal failure, transplantation and 
use of immunosuppressive drugs, and intravenous drug 
abuse [1, 3]. Its initial signs and symptoms are usually 
subtle and can be easily overlooked or misdiagnosed 
as a more benign condition [2], specially erysipelas.
Pyomyositis can affect any muscle group, infect-
ing by contiguity or hematogenous spread [1, 5]. The 
main agents are Gram-positive cocci [3], and the most 
common etiologic agent is Staphylococcus aureus, in 
up to 85–95% of the cases [1, 2, 5] — with increasing 
frequency of resistance to methicillin (MRSA) [2].
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Case report
The patient is a 42 years old, Brazilian male, se-
curity agent, referred to the emergency department 
complaining of a acute pain of severe intensity on both 
thighs, restraining flexion of both lower limbs for the 
last seven days. He reported that a less severe pain had 
been present for over two months, and, one month 
earlier, he was hospitalized for 15 days due to erysipelas 
in his right leg — received analgesics without improve-
ment at that time. He denied smoking or trauma, 
reporting, just social drinking; as a family background 
his father was diabetic and his mother had arterial hy-
pertension. Physical examination of the patient showed 
a hyperemic, swollen and painful right leg, especially 
in the calf; his body temperature was 38.2º C pulse of 
98 ppm and blood pressure of 150 over 80 mm Hg. 
Laboratory workup showed increased leukocyte count 
(18,452 hg/mm3) and elevated c-reactive protein 
15 mg/dL. Throughout this hospitalization, he was also 
diagnosed with type 2 diabetes mellitus and systemic 
arterial hypertension, having started treatment since 
then, and had good glucose control throughout hos-
pitalization with metformin.
During the first hospitalization, a magnetic reso-
nance image (MRI) of the right leg was performed 
(Figure 1 — description on the legend), but it might had 
been neglected. Given the progression of symptoms and 
severity of the clinical setting, a new MRI of both thighs was 
performed (Figure 2 — description on the legend), which 
showed purulent collection affecting both legs, rising the 
diagnosis of bilateral pyomyositis stage 2. Patient started 
to receive ceftriaxone plus teicoplanin empirically, and after 
2 weeks was discharged with complete resolution.
Discussion
The diagnosis of pyomyositis can be challenging 
due to the nonspecific clinical signs at onset [2]. It may 
be confused with bone or joint infection processes, 
thrombophlebitis, panniculitis or systemic diseases 
[2]. The differential diagnosis includes muscle trauma, 
deep vein thrombosis, osteomyelitis, cellulitis, septic 
arthritis, and malignant tumors [2]. 
Figure 2. MRI of the thighs in the coronal section T2 STIR in A and axial section in B, demonstrating swelling of the right vastus 
lateralis and left femoral biceps muscles (white arrows in A) with collection in the right vastus medius muscle (white arrow in B), 
edema of the other muscles bellies with subfascial and peripheral fluid (gray arrow in B)
Figure 1. MRI of the right leg in the axial section T1-weighted sequence in A, T2 STIR in B and T1 sequence with contrast in C 
demonstrating a collection between the musculature and subcutaneous tissue with peripheral contrast enhancement (white arrows)
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In the case of diabetic patients, it appears that 
muscular and circulatory disorders which, together 
with granulocyte dysfunction and decreased cellular 
immunity, increase the risk of developing pyomyositis 
[4]. Laboratory findings are nonspecific and the blood 
count may show leukopenia or leukocytosis with left 
deviation, depending on the etiologic agent and the 
patient immune response [1, 4]. There may be increased 
inflammatory markers and generally does not affect 
kidney function [3, 5]. Blood cultures are positive in 
less than 40% of patients and secretion cultures are 
positive in only 21–41% of cases [6].
Usually, it only affects one muscle group, but in 11% 
to 43% of patients may have widespread outbreaks in 
various muscles, being quadriceps muscle the most af-
fected, followed by the gluteal and iliopsoas muscles [7]; 
iliopsoas pyomyositis occurs more commonly secondary 
to gastrointestinal or urinary tract infections [7].
Pyomyositis presents three evolutionary stages: 
invasive, purulent and late. The invasive stage is char-
acterized by insidious onset, where only about 2% of 
affected patients seek medical support. The purulent 
stage occurs about 10–21 days after symptom onset 
and is characterized by the abscess location and, at this 
stage, about 90% of patients seek medical care due 
to the severity of the symptoms. If the disease is not 
identified and treated properly with antibiotics and/or 
surgical drainage, evolution occurs for the so-called late 
period associated with significant systemic involvement 
like septic embolization, septic shock, and even death 
[8]. Our patient had a bilateral phase 2 pyomiositis, 
due to an initial misdiagnosis of erysipelas, when he 
was still on initial phase.
Imaging tests such as ultrasound, computed to-
mography (CT) and magnetic resonance imaging (MRI) 
are useful to identify the number, size, extension, loca-
tion of abscesses, and guide needle biopsy [9].
Ultrasound has high sensitivity for fluid collections 
detection; it may demonstrate initial muscle edema as 
a hypoechoic lesion with imprecise limits affecting one 
or more muscles that, with latter disease evolution, can 
lead to the formation of abscess [3].
CT scan shows enlargement and decreased at-
tenuation of the affected muscle, with a blurring of 
surrounding fat. The involvement of a muscle group 
that is disproportionate to the involvement of the 
subcutaneous tissue helps distinguish myositis from 
primary cellulitis. Intramuscular collections can be 
observed and contrast material is used to help differ-
entiate viable and necrotic muscles by demonstrating 
enhancement around the abscess [5, 7]. CT scan, as 
well as ultrasound, can help guide needle aspiration 
[3] and are also useful for surgical planning, with 
abscess drainage muscle followed by culture-guided 
antibiotics [5, 7].
MRI is the gold standard for the diagnosis by de-
tecting early findings of muscles diffuse inflammation 
[5], and may also guide biopsy of the affected muscles 
[10]. MRI can show extension of infection and evaluates 
adjacent structures, such as joints, bone, and other 
surrounding soft tissues, differentiating pyomyositis 
from other differential diagnosis.
Treatment with antibiotics in conjunction with sur-
gical drainage or suction, when applicable, is generally 
sufficient; prognosis is good with early diagnosis and 
appropriate treatment, depending on the underlying 
comorbities [11, 12]. Usually, one antibiotic with S. au-
reus coverage such as oxacillin, ciprofloxacin or cepha-
losporins is enough, but when dealing with immuno-
compromised patients, association of a amynoglicoside 
or even glycopeptides may be useful [13].
Untreated pyomyositis complications may include 
compartment syndrome, progression infection to septic 
arthritis, osteomyelitis and even death, which ranges 
between in up to 10% of the cases [5, 7]. In the long 
term, patients may experience weakness, and muscle 
dysfunction [5, 7].
In conclusion, pyomyositis may have subtle symp-
toms that are easily misinterpreted as signs of a more 
common and benign infection. Imaging tests facilitate 
early diagnosis and treatment through the direct location 
of the lesions and, when it’s necessary, assist invasive 
procedures such as biopsy and abscess aspiration. The 
early recognition of the disease allows an earlier treat-
ment preventing the development of complications.
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